ÂÜÀòÂÒÂ×

Helmut Kogler, MBA, currently serves as Vice President - Head of Commercial Biosimilars Germany at Fresenius Kabi since December 2023. Prior to this role, Kogler was Head of Sales Biosimilars Germany at STADA Group from October 2022 to November 2023 and held multiple senior positions at Viatris between March 2020 and September 2022, including Head of Hospital/Biosimilars and OTC Austria and Commercial Lead for both Austria and Switzerland. Kogler's career also includes serving as Head of Sales at Mylan in 2020 and Director at AbbVie from January 2013 to February 2020, where responsibilities encompassed sales, marketing, and digital innovations. Additionally, Kogler served as Market Access Lead at Abbott from 1995 to 2012. Helmut Kogler earned an MBA in Sales and Innovation from FH Wiener Neustadt between 2017 and 2019.